Qiagen leaps across Atlantic to buy synthetic DNA maker; push into U.S. continues with $110 million stock swap
Article Abstract:
The article focuses on Qiagen N.V.'s agreement to purchase Operon Technologies Inc. in a stock swap valued at $110 million (Euro115.4 million). Privately held Operon will be the largest purchase yet for Qiagen, a biotech firm.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Shire to Purchase BioChem of Canada In Stock Agreement
Article Abstract:
Shire Pharmaceuticals Group PLC will acquire BioChem Pharma Inc. for $4 billion in Shire stock.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Qiagen acquires Sawady of Japan in stock deal
Article Abstract:
Qiagen NV has purchased Japan-based Sawady group for approximately $18 million (20.1 million euros). Sawady is Japan's second-largest synthetic nucleic acid supplier.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Phillips is close to acquiring Tosco for $7 billion in stock. Occidental is set to acquire Altura for $3.5 billion
- Abstracts: Spain's Santander, Abbey National of U.K. poised for $15 billion deal . Standard Chartered bids to buy Grindlays for $1.6 billion
- Abstracts: Nortel negotiates to buy Swiss plant from JDS for $3 billion in stock. Nortel Networks will acquire Xros in stock deal
- Abstracts: ABN Amro sues APP, three units to recover $31 million in debt. World Online shareholders look to Sue Brink, ABN Amro
- Abstracts: SAirGroup to sell Swissotel to Raffles for 340 million euros. SAirGroup agrees to buy control of Sabena in share-swap deal